Why the study?
Does selective destruction of neuronal perikarya in the central nucleus of the amygdala alter the development of hypertension in spontaneously hypertensive rats?
Does selective destruction of neuronal perikarya in the central nucleus of the amygdala alter the development of hypertension in spontaneously hypertensive rats?
Destruction of neuronal perikarya in the central nucleus of the amygdala in young spontaneously hypertensive rats merely delays the development of hypertension, primarily due to reduced weight gain.
Higher late MAP after amygdala lesions in food-equalized SHR; leaves open central mechanisms and precludes clinical translation.
Electrolytic lesions of the central nucleus of the amygdala (ACe) have been shown to attenuate the development of hypertension in spontaneously hypertensive rats (SHR). Whether this was due to destruction of local neurons and/or fibers is unknown. In the present study, neuronal perikarya in the ACe of 4-wk-old SHR were selectively destroyed with ibotenic acid. In two experiments, each comprising lesioned and sham-lesioned SHR, mean arterial blood pressure (MAP) was measured 7 and 15 wk after operation in the second experiment also at 22 wk. In the first experiment, in which rats were fed ad libitum, lesioned SHR had significantly lower body weights from 5 wk postoperation onward, and at 15 wk postoperation their average MAP [173 +/- 7 mmHg (SE)] was significantly lower vs. sham-lesioned SHR (201 +/- 4 mmHg). In the second experiment, food intake, and hence body weight, among the lesioned and sham-lesioned rats was equalized. Average MAP in the lesioned SHR at 7 and 15 wk postoperation was not different vs. sham-lesioned SHR but was significantly higher (191 +/- 6 mmHg) vs. sham-lesioned SHR but was significantly higher (191 +/- 6 mmHg) vs. sham-lesioned SHR (164 +/- 5 mmHg) 22 wk postoperation. These results indicate that destruction of neuronal perikarya in the ACe in young SHR merely delays the development of hypertension, due to a reduced weight gain.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: